Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 9/20 | 0.45 |
| ▸ | ACE | P12821 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | KDM5A | P29375 | 1/20 | 0.44 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.43 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.43 |
| ▸ | REN | P00797 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29442098 | 0.93 | KDM1A (0.47) | KDM1AOPRM1OPRK1MAOBKDM5A | |
| SCHEMBL7351817 | 0.93 | MAPK8 (0.41) | KDM1AOPRM1OPRK1ACEMAOB | |
| SCHEMBL7351804 | 0.93 | MAPK8 (0.41) | KDM1AOPRM1OPRK1ACEMAOB | |
| SCHEMBL29855959 | 0.92 | KDM1A (0.47) | KDM1AOPRM1OPRK1ACEMAOB | |
| SCHEMBL29548952 | 0.92 | KDM1A (0.48) | KDM1AOPRM1OPRK1MAOBKDM5A | |
| SCHEMBL31696335 | 0.90 | KDM1A (0.54) | KDM1AOPRM1OPRK1MAOBKDM5A | |
| SCHEMBL3865485 | 0.89 | MAPK8 (0.50) | KDM1AOPRM1OPRK1MAOBKDM5A | |
| SCHEMBL31165809 | 0.89 | MAPK8 (0.45) | KDM1AOPRM1OPRK1MAOBKDM5A | |
| SCHEMBL29588517 | 0.88 | ACE (0.52) | ACEREN | |
| SCHEMBL29837381 | 0.87 | MAPK8 (0.43) | KDM1AOPRM1OPRK1MAOBKDM5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220120732-A1 | TREATMENT OF DISEASES WITH MULTIMERIC PEPTIDES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2022-04-21 | — | — | US | disclosed |